行情

GNMK

GNMK

GenMark诊断
NASDAQ

实时行情|Nasdaq Last Sale

17.14
+0.20
+1.18%
交易中 13:20 07/14 EDT
开盘
16.98
昨收
16.94
最高
17.32
最低
16.42
成交量
61.73万
成交额
--
52周最高
19.83
52周最低
3.360
市值
11.94亿
市盈率(TTM)
-23.6349
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测GNMK价格均价为19.25,最高价位20.00,最低价为18.00。

EPS

GNMK 新闻

更多
GenMark's Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in GenMark Diagnostics.
Zacks · 6小时前
Keep buying hot stocks like Slack and Costco, Wall Street's best-performing analysts say
We used TipRanks analyst ranking service to pinpoint Wall Street's best-performing analysts.
CNBC.com · 2天前
GenMark Diagnostics (GNMK) Stock Is a Winner, But How Much Higher Can It Go?
The coronavirus has had a negative impact on most but as luck would have it, some companies have benefited from the viral outbreak. Along with those catering to the stay at home climate, healthcare companies’ valuations have soared during the pandemic. You can
SmarterAnalyst · 4天前
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8)
Benzinga · 5天前
Why GenMark Diagnostics Stock Is Soaring Today
Shares of GenMark Diagnostics (NASDAQ: GNMK) were soaring 21.6% as of 11:44 a.m. EDT on Wednesday. The big jump came after GenMark provided preliminary second-quarter results Tuesday evening. It's easy to see why investors reacted positively to GenMark's Q2
Motley Fool · 6天前
Covid Report: Coronavirus Test Maker GenMark Diagnostics Jumps On Sales Beat
Investor's Business Daily · 6天前
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
Benzinga · 6天前
BIIB, MFGP among premarket gainers
Seeking Alpha - Article · 6天前

所属板块

先进医疗设备和技术
+0.78%
医疗设备和用品
+0.72%

热门股票

代码
价格
涨跌幅

GNMK 简况

GenMark Diagnostics, Inc.是一家分子诊断公司。该公司致力于开发和商业化有助于诊断复杂医学状况的复合分子检测。它基于eSensor电化学检测技术开发并商业化复合分子测试。它提供了四种食品与药物管理局(FDA)批准的在XT-8仪器上运行的诊断测试,包括呼吸病毒检测、囊性纤维化基因分型测试、华法林敏感性测试和血栓形成风险测试。它还提供了丙型肝炎(HCV)基因分型测试和相关的定制试剂,以及2C19基因分型测试,其版本可与XT-8仪器一起仅供研究使用(RUO)。其XT-8和ePlex测试盒通过使用不同的电极和多个信号探针的组合从单个样品中检测出数十种目标生物标志物,从而实现了多重测试。
展开

微牛提供GenMark Diagnostics, Inc(NASDAQ-GNMK)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的GNMK股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易GNMK股票基本功能。